These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 17502550

  • 1. Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome?
    Chitravas N, Dewey HM, Nicol MB, Harding DL, Pearce DC, Thrift AG.
    Neurology; 2007 May 15; 68(20):1687-93. PubMed ID: 17502550
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of prestroke use of angiotensin-converting enzyme inhibitors alone versus combination with antiplatelets and statin on ischemic stroke outcome.
    Hassan Y, Al-Jabi SW, Aziz NA, Looi I, Zyoud SH.
    Clin Neuropharmacol; 2011 May 15; 34(6):234-40. PubMed ID: 21996648
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Blood pressure and antihypertensive therapy as predictors of early outcome in acute ischemic stroke.
    Keezer MR, Yu AY, Zhu B, Wolfson C, Côté R.
    Cerebrovasc Dis; 2008 May 15; 25(3):202-8. PubMed ID: 18212508
    [Abstract] [Full Text] [Related]

  • 9. Impact of prestroke oral anticoagulation on severity and outcome of ischemic and hemorrhagic stroke in patients with atrial fibrillation.
    Audebert HJ, Schenk B, Schenkel J, Heuschmann PU.
    Cerebrovasc Dis; 2010 May 15; 29(5):476-83. PubMed ID: 20299787
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.
    Lip GY, Frison L, Grind M.
    J Intern Med; 2007 Jun 15; 261(6):577-86. PubMed ID: 17547713
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
    Mancini GB, Etminan M, Zhang B, Levesque LE, FitzGerald JM, Brophy JM.
    J Am Coll Cardiol; 2006 Jun 20; 47(12):2554-60. PubMed ID: 16781387
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG.
    J Indian Med Assoc; 2009 Mar 20; 107(3):178-82. PubMed ID: 19810392
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
    Feringa HH, Bax JJ, Karagiannis SE, Noordzij P, van Domburg R, Klein J, Poldermans D.
    Arch Gerontol Geriatr; 2009 Mar 20; 48(1):116-20. PubMed ID: 18177954
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.